[144] ResMed Inc. SEC Filing

Rhea-AI Filing Summary

Aegon Ltd. (AEG) has filed a Form 6-K to confirm the launch of its previously announced €200 million share buyback starting 1 July 2025. The program, authorised by shareholders on 12 June 2025, is scheduled to run until 15 December 2025, subject to market conditions.

• A third-party broker will repurchase common shares on Euronext Amsterdam at prices not exceeding the average daily VWAP over the period.
• Vereniging Aegon, the company’s largest shareholder holding about 18.4 % of voting rights, will participate on a pro-rata basis, representing up to €37 million of the total buyback.
• Aegon intends to cancel all repurchased shares, permanently reducing share count and potentially enhancing EPS and ROE.
• The program will be conducted under the EU Market Abuse Regulation and within the shareholder authority granted at the 2025 AGM.

No new financial results were disclosed; the rest of the filing consists of standard forward-looking-statement language and an extensive risk factor list.

Positive

• Initiation of €200 million share buyback scheduled to complete by 15 Dec 2025
• All repurchased shares will be cancelled, enhancing per-share metrics
• Largest shareholder participates pro-rata, maintaining ownership balance

Negative

• None.

Insights

Financial Analyst

TL;DR: €200 m buyback signals management’s confidence and should be modestly accretive for remaining shareholders.

The announced repurchase equals a meaningful capital return and, because the shares will be cancelled, directly reduces the float, increasing each remaining share’s claim on future earnings and dividends. Pro-rata participation by Vereniging Aegon avoids ownership distortion and supports orderly execution. While the filing gives no current cash or leverage data, the board’s decision implies headroom within capital and solvency targets. Execution through an independent broker and price caps at VWAP average contain market-impact risk. Overall, the move is a shareholder-friendly allocation of surplus capital and a positive signal about management’s view of intrinsic value.

Corporate Governance Specialist

TL;DR: Governance framework appears sound; buyback complies with shareholder authority and MAR rules.

Shareholder approval obtained at the June 2025 AGM meets best-practice standards. Pro-rata participation by the controlling foundation mitigates governance concerns about minority dilution. Cancellation of shares prevents management from building treasury stock that could be used for entrenchment. Disclosure regarding broker engagement and compliance with the EU Market Abuse Regulation further strengthens transparency. No adverse governance red flags are evident.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3883	997892.17	146627399	07/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/11/2024	Restricted Stock Vesting	Issuer			1000	11/11/2024	Compensation
Common	07/01/2025	Option Granted - 11/14/2018	Issuer			2883	07/01/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Brett Sandercock 9001 Spectrum Center Blvd. San Diego CA 92123	Common	04/08/2025	1000	215580.00
Brett Sandercock 9001 Spectrum Center Blvd. San Diego CA 92123	Common	05/22/2025	3644	891285.96
Brett Sandercock 9001 Spectrum Center Blvd. San Diego CA 92123	Common	06/02/2025	1000	243780.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How large is Aegon (AEG)’s new share buyback program?

The program totals €200 million in common share repurchases.

When will the AEG buyback run?

It starts on 1 July 2025 and is expected to finish by 15 December 2025.

Will Aegon cancel the repurchased shares?

Yes, Aegon intends to cancel all shares bought under this program.

How is Vereniging Aegon involved in the buyback?

The largest shareholder will participate pro-rata, selling up to €37 million worth of shares.

Where can investors track the buyback progress?

Updates will be posted on Aegon’s share buyback updates page at aegon.com.